105 related articles for article (PubMed ID: 23244593)
1. Activity-based exposure comparisons among humans and nonclinical safety testing species in an extensively metabolized drug candidate.
Zhu X; Slatter JG; Emery MG; Deane MR; Akrami A; Zhang X; Hickman D; Skiles GL; Subramanian R
Xenobiotica; 2013 Jul; 43(7):617-27. PubMed ID: 23244593
[TBL] [Abstract][Full Text] [Related]
2. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers.
Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG
Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitor.
Gibbs JP; Emery MG; McCaffery I; Smith B; Gibbs MA; Akrami A; Rossi J; Paweletz K; Gastonguay MR; Bautista E; Wang M; Perfetti R; Daniels O
J Clin Pharmacol; 2011 Jun; 51(6):830-41. PubMed ID: 20663992
[TBL] [Abstract][Full Text] [Related]
4. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
5. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
Gao H; Deng S; Obach RS
Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
[TBL] [Abstract][Full Text] [Related]
6. Assessment of exposure of metabolites in preclinical species and humans at steady state from the single-dose radiolabeled absorption, distribution, metabolism, and excretion studies: a case study.
Prakash C; Li Z; Orlandi C; Klunk L
Drug Metab Dispos; 2012 Jul; 40(7):1308-20. PubMed ID: 22474055
[TBL] [Abstract][Full Text] [Related]
7. Intestinal and hepatic first-pass extraction of the 11β-HSD1 inhibitor AMG 221 in rats with chronic vascular catheters.
Gao Q; Kimura RE; Zhang X; Nam J; Amore BM; Hickman D; Greg Slatter J; Emery MG
Xenobiotica; 2014 Mar; 44(3):264-9. PubMed ID: 23517558
[TBL] [Abstract][Full Text] [Related]
8. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
[TBL] [Abstract][Full Text] [Related]
9. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
10. Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11β-hydroxysteroid dehydrogenase 1.
Nishihara M; Takahashi J; Kondo T; Mouri K; Asahi S
Drug Res (Stuttg); 2014 Sep; 64(9):476-84. PubMed ID: 24357138
[TBL] [Abstract][Full Text] [Related]
11. Metabolites in safety testing.
Robison TW; Jacobs A
Bioanalysis; 2009 Oct; 1(7):1193-200. PubMed ID: 21083045
[TBL] [Abstract][Full Text] [Related]
12. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments (metabolites in safety testing). II. Application to unstable metabolites.
Gao H; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1290-6. PubMed ID: 22456937
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of lumateperone in vitro and in vivo by UPLC-Q Exactive Orbitrap HRMS, and its pharmacokinetic study in rat plasma by LC-MS/MS.
Qiu Y; Guo J; Chen J; Zhang W; Wang W
J Pharm Biomed Anal; 2024 Aug; 246():116221. PubMed ID: 38759324
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
16. An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing.
Tonn GR; Wong SG; Wong SC; Johnson MG; Ma J; Cho R; Floren LC; Kersey K; Berry K; Marcus AP; Wang X; Van Lengerich B; Medina JC; Pearson PG; Wong BK
Drug Metab Dispos; 2009 Mar; 37(3):502-13. PubMed ID: 19088267
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
18. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
[TBL] [Abstract][Full Text] [Related]
19. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap.
Gao H; Materne OL; Howe DL; Brummel CL
Rapid Commun Mass Spectrom; 2007; 21(22):3683-93. PubMed ID: 17937450
[TBL] [Abstract][Full Text] [Related]
20. Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery.
Bu W; Akama T; Chanda S; Sullivan D; Ciaravino V; Jarnagin K; Freund Y; Sanders V; Chen CW; Fan X; Heyman I; Liu L
J Pharm Biomed Anal; 2012 Nov; 70():344-53. PubMed ID: 22687459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
